TY  - GEN
AU  - Kim,In-Ho
AU  - Lee,In Hee
AU  - Lee,Ji Eun
AU  - Hong,Sook Hee
AU  - Kim,Tae-Jung
AU  - Lee,Kyo-Young
AU  - Kim,Young Kyoon
AU  - Kim,Seung Joon
AU  - Sung,Sook Whan
AU  - Park,Jae Kil
AU  - Yoo,Ie Ryung
AU  - Kim,Yeon Sil
AU  - Kim,Jung-Oh
AU  - Kang,Jin Hyoung
TI  - Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma
SN  - 1534-4681
PY  - 2018///0223
KW  - Adenocarcinoma
KW  - genetics
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carboplatin
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - ErbB Receptors
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - Pneumonectomy
KW  - Proto-Oncogene Proteins c-met
KW  - metabolism
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1245/s10434-016-5599-z
ER  -